Maldives

Maldives

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
2.86 (2.37 - 3.39) 2019 Modelled IHME
2.86 (2.36 - 3.34) 2018 Modelled IHME
2.86 (2.32 - 3.36) 2017 Modelled IHME
2.84 (2.35 - 3.36) 2016 Modelled IHME
2.84 (2.33 - 3.36) 2015 Modelled IHME
2.85 (2.36 - 3.35) 2014 Modelled IHME
2.87 (2.38 - 3.38) 2013 Modelled IHME
2.91 (2.40 - 3.42) 2012 Modelled IHME
2.95 (2.43 - 3.47) 2011 Modelled IHME
2.99 (2.43 - 3.52) 2010 Modelled IHME
3.04 (2.49 - 3.55) 2009 Modelled IHME
3.1 (2.56 - 3.61) 2008 Modelled IHME
3.16 (2.62 - 3.70) 2007 Modelled IHME
3.23 (2.67 - 3.79) 2006 Modelled IHME
3.3 (2.70 - 3.94) 2005 Modelled IHME
3.37 (2.77 - 3.99) 2004 Modelled IHME
3.44 (2.82 - 4.08) 2003 Modelled IHME
3.52 (2.88 - 4.19) 2002 Modelled IHME
3.61 (2.92 - 4.30) 2001 Modelled IHME
3.7 (2.98 - 4.45) 2000 Modelled IHME
3.81 (3.07 - 4.58) 1999 Modelled IHME
3.93 (3.16 - 4.75) 1998 Modelled IHME
4.06 (3.25 - 4.91) 1997 Modelled IHME
4.18 (3.35 - 5.09) 1996 Modelled IHME
4.29 (3.41 - 5.29) 1995 Modelled IHME
4.38 (3.49 - 5.35) 1994 Modelled IHME
4.46 (3.55 - 5.46) 1993 Modelled IHME
4.54 (3.65 - 5.54) 1992 Modelled IHME
4.6 (3.69 - 5.63) 1991 Modelled IHME
4.66 (3.73 - 5.72) 1990 Modelled IHME
1.43 (0.12 - 14.80) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.48 (0.34 - 0.64) 2019 Modelled IHME
0.51 (0.36 - 0.66) 2018 Modelled IHME
0.53 (0.38 - 0.69) 2017 Modelled IHME
0.56 (0.41 - 0.73) 2016 Modelled IHME
0.58 (0.42 - 0.76) 2015 Modelled IHME
0.56 (0.41 - 0.73) 2014 Modelled IHME
0.51 (0.37 - 0.66) 2013 Modelled IHME
0.45 (0.33 - 0.57) 2012 Modelled IHME
0.39 (0.28 - 0.50) 2011 Modelled IHME
0.36 (0.26 - 0.46) 2010 Modelled IHME
0.34 (0.25 - 0.44) 2009 Modelled IHME
0.33 (0.23 - 0.42) 2008 Modelled IHME
0.32 (0.23 - 0.41) 2007 Modelled IHME
0.31 (0.22 - 0.40) 2006 Modelled IHME
0.31 (0.22 - 0.40) 2005 Modelled IHME
0.32 (0.23 - 0.42) 2004 Modelled IHME
0.37 (0.26 - 0.47) 2003 Modelled IHME
0.43 (0.30 - 0.56) 2002 Modelled IHME
0.52 (0.36 - 0.67) 2001 Modelled IHME
0.61 (0.42 - 0.80) 2000 Modelled IHME
0.75 (0.52 - 0.97) 1999 Modelled IHME
0.95 (0.68 - 1.24) 1998 Modelled IHME
1.21 (0.87 - 1.56) 1997 Modelled IHME
1.49 (1.07 - 1.94) 1996 Modelled IHME
1.78 (1.27 - 2.33) 1995 Modelled IHME
2.08 (1.50 - 2.71) 1994 Modelled IHME
2.41 (1.76 - 3.12) 1993 Modelled IHME
2.76 (2.03 - 3.62) 1992 Modelled IHME
3.15 (2.30 - 4.13) 1991 Modelled IHME
3.56 (2.60 - 4.70) 1990 Modelled IHME
0.19 (0.01 - 2.36) 2015 Modelled WHO
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.03 (2.37 - 3.81) 2019 Modelled IHME
2.95 (2.34 - 3.70) 2018 Modelled IHME
2.89 (2.31 - 3.58) 2017 Modelled IHME
2.84 (2.29 - 3.46) 2016 Modelled IHME
2.8 (2.28 - 3.43) 2015 Modelled IHME
2.79 (2.29 - 3.38) 2014 Modelled IHME
2.78 (2.30 - 3.34) 2013 Modelled IHME
2.78 (2.28 - 3.33) 2012 Modelled IHME
2.8 (2.28 - 3.36) 2011 Modelled IHME
2.8 (2.29 - 3.34) 2010 Modelled IHME
2.85 (2.32 - 3.39) 2009 Modelled IHME
2.92 (2.37 - 3.48) 2008 Modelled IHME
2.99 (2.43 - 3.56) 2007 Modelled IHME
3.07 (2.50 - 3.64) 2006 Modelled IHME
3.16 (2.55 - 3.76) 2005 Modelled IHME
3.3 (2.68 - 3.99) 2004 Modelled IHME
3.48 (2.85 - 4.20) 2003 Modelled IHME
3.66 (2.95 - 4.45) 2002 Modelled IHME
3.89 (3.09 - 4.76) 2001 Modelled IHME
3.97 (3.10 - 4.88) 2000 Modelled IHME
4.04 (3.13 - 4.97) 1999 Modelled IHME
4.25 (3.25 - 5.31) 1998 Modelled IHME
4.43 (3.32 - 5.67) 1997 Modelled IHME
4.54 (3.35 - 5.92) 1996 Modelled IHME
4.59 (3.32 - 6.04) 1995 Modelled IHME
4.72 (3.37 - 6.23) 1994 Modelled IHME
4.92 (3.47 - 6.50) 1993 Modelled IHME
5.1 (3.52 - 6.79) 1992 Modelled IHME
5.25 (3.59 - 7.02) 1991 Modelled IHME
5.4 (3.66 - 7.22) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
15 (12 - 19) 2019 Modelled IHME
14 (11 - 18) 2018 Modelled IHME
13 (11 - 17) 2017 Modelled IHME
13 (10 - 16) 2016 Modelled IHME
12 (10 - 15) 2015 Modelled IHME
12 (10 - 14) 2014 Modelled IHME
11 (9 - 13) 2013 Modelled IHME
11 (9 - 13) 2012 Modelled IHME
10 (9 - 13) 2011 Modelled IHME
10 (8 - 12) 2010 Modelled IHME
10 (8 - 12) 2009 Modelled IHME
10 (8 - 12) 2008 Modelled IHME
10 (8 - 12) 2007 Modelled IHME
10 (8 - 12) 2006 Modelled IHME
10 (8 - 12) 2005 Modelled IHME
10 (8 - 12) 2004 Modelled IHME
10 (8 - 12) 2003 Modelled IHME
11 (9 - 13) 2002 Modelled IHME
11 (9 - 14) 2001 Modelled IHME
11 (9 - 14) 2000 Modelled IHME
11 (9 - 14) 1999 Modelled IHME
12 (9 - 15) 1998 Modelled IHME
12 (9 - 15) 1997 Modelled IHME
12 (9 - 16) 1996 Modelled IHME
12 (9 - 16) 1995 Modelled IHME
12 (8 - 16) 1994 Modelled IHME
12 (8 - 16) 1993 Modelled IHME
12 (8 - 16) 1992 Modelled IHME
12 (8 - 16) 1991 Modelled IHME
12 (8 - 16) 1990 Modelled IHME
12 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
42 (34 - 52) 2019 Modelled IHME
42 (34 - 51) 2018 Modelled IHME
42 (33 - 51) 2017 Modelled IHME
41 (33 - 50) 2016 Modelled IHME
41 (33 - 50) 2015 Modelled IHME
41 (33 - 50) 2014 Modelled IHME
41 (32 - 50) 2013 Modelled IHME
41 (32 - 50) 2012 Modelled IHME
40 (32 - 50) 2011 Modelled IHME
40 (31 - 50) 2010 Modelled IHME
40 (31 - 50) 2009 Modelled IHME
40 (31 - 51) 2008 Modelled IHME
40 (31 - 51) 2007 Modelled IHME
41 (31 - 51) 2006 Modelled IHME
41 (32 - 52) 2005 Modelled IHME
42 (32 - 52) 2004 Modelled IHME
42 (33 - 53) 2003 Modelled IHME
43 (33 - 53) 2002 Modelled IHME
43 (33 - 54) 2001 Modelled IHME
44 (34 - 54) 2000 Modelled IHME
44 (34 - 55) 1999 Modelled IHME
44 (34 - 55) 1998 Modelled IHME
45 (35 - 56) 1997 Modelled IHME
45 (35 - 56) 1996 Modelled IHME
45 (36 - 56) 1995 Modelled IHME
46 (36 - 57) 1994 Modelled IHME
46 (36 - 57) 1993 Modelled IHME
46 (37 - 57) 1992 Modelled IHME
47 (37 - 57) 1991 Modelled IHME
47 (38 - 58) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
99 2018 Survey/reported WHO/UNICEF
99 2017 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
99 2018 Survey/reported WHO/UNICEF
99 2017 Survey/reported WHO/UNICEF
99 2016 Survey/reported WHO/UNICEF
99 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
99 2013 Survey/reported WHO/UNICEF
99 2012 Survey/reported WHO/UNICEF
96 2011 Survey/reported WHO/UNICEF
97 2010 Survey/reported WHO/UNICEF
98 2009 Survey/reported WHO/UNICEF
98 2008 Survey/reported WHO/UNICEF
98 2007 Survey/reported WHO/UNICEF
98 2006 Survey/reported WHO/UNICEF
98 2005 Survey/reported WHO/UNICEF
97 2004 Survey/reported WHO/UNICEF
98 2003 Survey/reported WHO/UNICEF
98 2002 Survey/reported WHO/UNICEF
98 2001 Survey/reported WHO/UNICEF
96 2000 Survey/reported WHO/UNICEF
90 1999 Survey/reported WHO/UNICEF
45 1998 Survey/reported WHO/UNICEF
50 1997 Survey/reported WHO/UNICEF
96 1996 Survey/reported WHO/UNICEF
80 1995 Survey/reported WHO/UNICEF
63 1994 Survey/reported WHO/UNICEF
21 1993 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.21 (0.97 - 1.50) 2019 Modelled IHME
1.21 (0.97 - 1.50) 2018 Modelled IHME
1.2 (0.96 - 1.49) 2017 Modelled IHME
1.19 (0.96 - 1.46) 2016 Modelled IHME
1.17 (0.95 - 1.44) 2015 Modelled IHME
1.17 (0.95 - 1.44) 2014 Modelled IHME
1.18 (0.95 - 1.45) 2013 Modelled IHME
1.19 (0.96 - 1.47) 2012 Modelled IHME
1.2 (0.96 - 1.49) 2011 Modelled IHME
1.21 (0.96 - 1.51) 2010 Modelled IHME
1.21 (0.98 - 1.52) 2009 Modelled IHME
1.22 (0.98 - 1.52) 2008 Modelled IHME
1.23 (0.98 - 1.52) 2007 Modelled IHME
1.24 (0.99 - 1.54) 2006 Modelled IHME
1.25 (0.99 - 1.55) 2005 Modelled IHME
1.25 (1 - 1.56) 2004 Modelled IHME
1.26 (1.01 - 1.57) 2003 Modelled IHME
1.27 (1.02 - 1.58) 2002 Modelled IHME
1.28 (1.02 - 1.59) 2001 Modelled IHME
1.29 (1.03 - 1.62) 2000 Modelled IHME
1.31 (1.05 - 1.63) 1999 Modelled IHME
1.33 (1.06 - 1.66) 1998 Modelled IHME
1.36 (1.08 - 1.70) 1997 Modelled IHME
1.39 (1.09 - 1.74) 1996 Modelled IHME
1.41 (1.11 - 1.78) 1995 Modelled IHME
1.44 (1.13 - 1.80) 1994 Modelled IHME
1.46 (1.16 - 1.82) 1993 Modelled IHME
1.49 (1.17 - 1.85) 1992 Modelled IHME
1.51 (1.20 - 1.89) 1991 Modelled IHME
1.54 (1.22 - 1.93) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0.7 (0 - 1.70) 2008 Modelled Degenhardt L et al, 2017

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.81 (2.17 - 3.57) 2019 Modelled IHME
2.76 (2.14 - 3.48) 2018 Modelled IHME
2.72 (2.13 - 3.38) 2017 Modelled IHME
2.67 (2.12 - 3.30) 2016 Modelled IHME
2.65 (2.11 - 3.24) 2015 Modelled IHME
2.62 (2.09 - 3.19) 2014 Modelled IHME
2.59 (2.08 - 3.13) 2013 Modelled IHME
2.56 (2.05 - 3.08) 2012 Modelled IHME
2.53 (2.04 - 3.03) 2011 Modelled IHME
2.51 (2.01 - 2.99) 2010 Modelled IHME
2.51 (2 - 3.02) 2009 Modelled IHME
2.5 (1.98 - 3) 2008 Modelled IHME
2.47 (1.95 - 2.97) 2007 Modelled IHME
2.45 (1.94 - 2.98) 2006 Modelled IHME
2.43 (1.89 - 2.99) 2005 Modelled IHME
2.41 (1.88 - 2.99) 2004 Modelled IHME
2.4 (1.87 - 3.03) 2003 Modelled IHME
2.37 (1.81 - 3.06) 2002 Modelled IHME
2.41 (1.82 - 3.15) 2001 Modelled IHME
2.38 (1.74 - 3.17) 2000 Modelled IHME
2.39 (1.73 - 3.18) 1999 Modelled IHME
2.48 (1.78 - 3.38) 1998 Modelled IHME
2.58 (1.78 - 3.56) 1997 Modelled IHME
2.62 (1.79 - 3.64) 1996 Modelled IHME
2.62 (1.77 - 3.65) 1995 Modelled IHME
2.67 (1.79 - 3.72) 1994 Modelled IHME
2.75 (1.81 - 3.89) 1993 Modelled IHME
2.82 (1.82 - 4.02) 1992 Modelled IHME
2.87 (1.83 - 4.07) 1991 Modelled IHME
2.9 (1.84 - 4.13) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
14 (11 - 18) 2019 Modelled IHME
13 (10 - 17) 2018 Modelled IHME
13 (10 - 16) 2017 Modelled IHME
12 (10 - 15) 2016 Modelled IHME
11 (9 - 14) 2015 Modelled IHME
11 (9 - 13) 2014 Modelled IHME
10 (8 - 13) 2013 Modelled IHME
10 (8 - 12) 2012 Modelled IHME
9 (8 - 11) 2011 Modelled IHME
9 (7 - 11) 2010 Modelled IHME
9 (7 - 10) 2009 Modelled IHME
8 (7 - 10) 2008 Modelled IHME
8 (6 - 10) 2007 Modelled IHME
8 (6 - 9) 2006 Modelled IHME
8 (6 - 9) 2005 Modelled IHME
7 (6 - 9) 2004 Modelled IHME
7 (6 - 9) 2003 Modelled IHME
7 (5 - 9) 2002 Modelled IHME
7 (5 - 9) 2001 Modelled IHME
7 (5 - 9) 2000 Modelled IHME
7 (5 - 9) 1999 Modelled IHME
7 (5 - 9) 1998 Modelled IHME
7 (5 - 10) 1997 Modelled IHME
7 (5 - 10) 1996 Modelled IHME
7 (5 - 9) 1995 Modelled IHME
7 (4 - 9) 1994 Modelled IHME
7 (4 - 9) 1993 Modelled IHME
7 (4 - 10) 1992 Modelled IHME
7 (4 - 9) 1991 Modelled IHME
6 (4 - 9) 1990 Modelled IHME
6 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
24 (17 - 32) 2019 Modelled IHME
25 (18 - 32) 2018 Modelled IHME
25 (18 - 33) 2017 Modelled IHME
25 (18 - 33) 2016 Modelled IHME
25 (18 - 33) 2015 Modelled IHME
25 (18 - 33) 2014 Modelled IHME
25 (18 - 33) 2013 Modelled IHME
25 (18 - 33) 2012 Modelled IHME
25 (18 - 33) 2011 Modelled IHME
25 (18 - 33) 2010 Modelled IHME
25 (18 - 33) 2009 Modelled IHME
25 (18 - 33) 2008 Modelled IHME
25 (18 - 33) 2007 Modelled IHME
25 (17 - 33) 2006 Modelled IHME
25 (17 - 33) 2005 Modelled IHME
25 (17 - 33) 2004 Modelled IHME
24 (17 - 33) 2003 Modelled IHME
24 (16 - 32) 2002 Modelled IHME
24 (16 - 32) 2001 Modelled IHME
24 (16 - 32) 2000 Modelled IHME
23 (16 - 31) 1999 Modelled IHME
23 (15 - 31) 1998 Modelled IHME
23 (15 - 31) 1997 Modelled IHME
23 (15 - 31) 1996 Modelled IHME
23 (15 - 31) 1995 Modelled IHME
22 (15 - 31) 1994 Modelled IHME
23 (15 - 31) 1993 Modelled IHME
23 (15 - 31) 1992 Modelled IHME
22 (15 - 31) 1991 Modelled IHME
22 (15 - 30) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
15
2019
(12 - 19)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
14
2019
(11 - 18)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
99 (%)
2018
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines